Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

miércoles, 5 de noviembre de 2025, 7:49 am ET1 min de lectura
OCUL--

Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

Ocular Therapeutix: Chardan Capital maintains Buy, raises PT to $21.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios